Sign In  |  Register  |  About Walnut Creek Guide  |  Contact Us

Walnut Creek, CA
September 01, 2020 1:43pm
7-Day Forecast | Traffic

  • Search Hotels in Walnut Creek Guide

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mind Medicine Mindmed Inc (NQ: MNMD )

7.560 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Mind Medicine Mindmed Inc

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
31 32 Next >
Psyched: Atai, MindMed, Enveric and Mydecine Release 2021 Earnings, Bienstar Expands To Brazil & More!
It’s earnings week in the psychedelics space, opening a new window into the financial situations of many companies in the sector. 
Via Benzinga
Psychedelic Stock Gainers And Losers From April 5, 2022
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 1.60% at $1.27 LOSERS: 
Via Benzinga
MindMed Appoints Francois Lilienthal As New CCO
With over twenty years of experience in the biopharmaceutical industry, Francois Lilienthal, MD, has joined Mind Medicine Inc. ... 
Via Benzinga
From Pharma To Psychedelics, Robert Barrow, CEO Of MindMed: Meet Our Speakers
With over ten years of experience in the pharmaceutical industry, Robert Barrow, CEO of Mind Medicine Inc. (NASDAQ: MNMD) is someone ... 
Via Benzinga
Revive Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 6.06% at $14.18 
Via Benzinga
Are Psychedelics Stocks In Trouble Or Is The Market Reaching Maturity?
Long gone is the heyday of investor enthusiasm and easy access to capital that marked the launch of the psychedelics industry into the public markets. In recent months, psychedelics stocks entered into... 
Via Benzinga
3 Psychedelic Stocks to Buy for Oregon’s Magic Mushroom Bill
Psychedelic medical treatments and therapies are gaining in popularity, and these psychedelic stocks could benefit as the market emerges. 
Via InvestorPlace
Cybin, Seelos Therapeutics Among Top Psychedelic Movers Of Today
GAINERS: Cybin (AMEX:CYBN) shares closed up 5.26% at $0.86 
Via Benzinga
March Update: Psychedelic Compounds-Based Drug Stocks Index Went Down -19%
An update on the revisions that have been made to the Pure-Play Psychedelic Compounds-Based Drug Stocks Index with the increase in the minimum market capitalization required to be included in the... 
Via Talk Markets
Field Trip Health, Revive Therapeutics Among Top Psychedelic Movers Of Today
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 3.38% at $0.27 
Via Benzinga
Revive Therapeutics, Allied Among Top Psychedelic Movers Of Today
GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 4.22% at $0.46 
Via Benzinga
Demand for Toad Venom Rises Along With the Booming Psychedelics Market
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – March 30, 2022 – Depression and anxiety affect millions around the world and the venom of a toad is the latest psychedelic... 
Via FinancialNewsMedia
Psychedelic Stock Gainers And Losers From March 29, 2022
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 9.05% at $5.42 
Via Benzinga
Psyched: Third Michigan City Decriminalizes Psychedelics, MindMed Reports $133M Cash Position, Real Brands To Enter The Space
The psychedelics legislative landscape continues to move forward with Hazel Park,Michiganenacting decriminalization ... 
Via Benzinga
Mindset Pharma, Small Pharma Among Top Psychedelic Movers Of Today
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 8.24% at $0.18 
Via Benzinga
MindMed Reports Full Year 2021 Financial Results, Announces Changes In Leadership
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED) reported its financial results for the full year ended December 31, ... 
Via Benzinga
Earnings Scheduled For March 28, 2022
Companies Reporting Before The Bell • LGL Group (AMEX:LGL) is likely to report quarterly earnings at $0.10 per share on revenue of $7.20 million. 
Via Benzinga
Psychedelic Compounds-Based Drug Stocks Down Slightly This Past Week
We're tracking 13 public companies (US and/or Canada) doing clinical-stage research into THC and/or psychedelics for treating mental illnesses. While a few were up this week, the overall trend... 
Via Talk Markets
Psychedelic Stock Gainers And Losers From March 25, 2022
GAINERS: Allied (OTC: 
Via Benzinga
Allied, Field Trip Health Among Top Psychedelic Movers Of Today
GAINERS: Allied (OTC: 
Via Benzinga
Five Companies Developing Second Generation Psychedelics For Mental Health
Along with the psychedelic renaissance came a new type of drug: second generation psychedelics. Developed from classic psychedelics ... 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 23, 2022
GAINERS: Compass Pathways (NASDAQ: 
Via Benzinga
Mindset Pharma, Compass Pathways Among Top Psychedelic Movers Of Today
GAINERS: Mind Medicine (NASDAQ: 
Via Benzinga
Psyched: MindCure Shuts Down Operations, Novamind And MindMed Partner For Study
The psychedelics space was shaken up on the news thatMindCure Health (OTC: MCURF) was shutting down operations. 
Via Benzinga
Field Trip Health, Mindset Pharma Among Top Psychedelic Movers Of Today
GAINERS: Field Trip Health (NASDAQ: 
Via Benzinga
Psychedelic Compounds-Based Drug Stocks Index Bounces Back
Updating the stock performances of the 13 constituents in our Pure-Play Marijuana and Psychedelic Compounds-Based Drug Stocks Index: up last week but still down 32% YTD. 
Via Talk Markets
Field Trip Health, Allied Among Top Psychedelic Movers Of Today
GAINERS: Field Trip Health (NASDAQ: 
Via Benzinga
'Psychedelics Companies Are Onto Something Extraordinary,' Says Kevin O'Leary: Meet Our Keynote Speakers
Whether you're into finances or just a fan of Shark Tank, chances are you know who Kevin O’L... 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 16, 2022
GAINERS: Mindset Pharma (OTC: 
Via Benzinga
Novamind To Host MindMed Phase IIb Trial For LSD Based Drug For Anxiety Treatment
Novamind Inc. (OTCQB: NVMDF) (CSE:NM) (FSE:HN2) has been selected by Mind Medicine, Inc. (NASDAQ: MNMD)(NEO:MMED) to host ... 
Via Benzinga
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
31 32 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 WalnutCreekGuide.com & California Media Partners, LLC. All rights reserved.